ALK and neuroblastoma: Initial efforts determined that the majority of these cases are associated with activating germline mutations in the anaplastic lymphoma kinase (ALK) gene [49,50,51,52], and subsequent studies identified ALK gene mutations or gene amplifications in up to 15% of sporadic high-risk neuroblastoma tumors [49,53].